Freyeur & Trogue in conjunction with Forepont Capital Partners, deploy long-term capital to fuel growth of new medicines and technologies that drive better healthcare outcomes.
Additionally, our longstanding relationships with a variety of capital providers across the globe enable us to provide our clients with exposure to well qualified investors to meet their capital requirements.
We drive asset acquisition and divestiture for growth-oriented companies. From identifying and pursuing companies with unlocked potential to licensing or spinning out non-core assets, we add unique value on both the buy-side and the sell-side.
Freyeur & Trogue helps businesses identify technology, licensing and partnership opportunities to fuel growth.
Freyeur & Trogue helps companies unlock growth potential and identify new growth opportunities to achieve their commercial ambition. We work closely with our clients to uncover where new growth could come from.
Optimize Customer Focus – Identify your company’s most valuable customers and how this might change in the future.
Reach Customers Effectively & Efficiently – Optimize advertising and communication strategy and brand investment to accelerate growth profitably.
We develop a plan and focus on the right steps to drive growth quickly and profitably.
Freyeur & Trogue works with organizations to uncover the underlying needs of customers and unmet market opportunities and translate them into business ideas that can grow quickly.
We help clients understand how and where to leverage new digital technology to drive growth efficiently.
We help organizations sustain growth in the long term by helping them to develop an innovation culture.